Literature DB >> 18628925

Long-term follow-up of patients with insomnia.

Leon D Rosenthal1, Diana C Dolan, Daniel J Taylor, Emily Grieser.   

Abstract

It has been suggested that patients with insomnia who are lost to follow-up continue to experience symptoms. From winter 2006 to spring 2007, we contacted consecutive patients initially seen at a multidisciplinary sleep medicine clinic 3 to 5 years earlier and asked them about continuing symptoms. Among the 58 patients who agreed to participate, 43 (74%) reported that they still experienced difficulty initiating and/or maintaining sleep. Thirty-one of those patients had continued to receive treatment, 11 from a sleep medicine specialist and the remainder from other physicians. The majority listed zolpidem or eszopiclone as their primary medication, and many took multiple medications, including over-the-counter drugs and alternative medications. Most patients with insomnia were unaware of cognitive-behavioral therapy. These findings emphasize the need for primary care physicians to monitor symptoms of insomnia and to remain vigilant about potential treatment complications.

Entities:  

Year:  2008        PMID: 18628925      PMCID: PMC2446417          DOI: 10.1080/08998280.2008.11928409

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  2 in total

1.  Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial.

Authors:  Børge Sivertsen; Siri Omvik; Ståle Pallesen; Bjørn Bjorvatn; Odd E Havik; Gerd Kvale; Geir Høstmark Nielsen; Inger Hilde Nordhus
Journal:  JAMA       Date:  2006-06-28       Impact factor: 56.272

2.  Amnestic sleep-related eating disorder associated with zolpidem.

Authors:  Timothy I Morgenthaler; Michael H Silber
Journal:  Sleep Med       Date:  2002-07       Impact factor: 3.492

  2 in total
  5 in total

1.  Enduring sleep complaints predict health problems: a six-year follow-up of the survey of health and retirement in Europe.

Authors:  Ephraim S Grossman
Journal:  Aging Ment Health       Date:  2016-08-02       Impact factor: 3.658

2.  Sleep restriction therapy and hypnotic withdrawal versus sleep hygiene education in hypnotic using patients with insomnia.

Authors:  Daniel J Taylor; Wolfgang Schmidt-Nowara; Carol A Jessop; John Ahearn
Journal:  J Clin Sleep Med       Date:  2010-04-15       Impact factor: 4.062

3.  Efficacy of eight months of nightly zolpidem: a prospective placebo-controlled study.

Authors:  Surilla Randall; Timothy A Roehrs; Thomas Roth
Journal:  Sleep       Date:  2012-11-01       Impact factor: 5.849

4.  Gender Differences in the Efficacy and Safety of Chronic Nightly Zolpidem.

Authors:  Timothy A Roehrs; Thomas Roth
Journal:  J Clin Sleep Med       Date:  2016-03       Impact factor: 4.062

5.  The relationship of primary health care use with persistence of insomnia: a prospective cohort study.

Authors:  Richard A Hayward; Kelvin P Jordan; Peter Croft
Journal:  BMC Fam Pract       Date:  2012-02-16       Impact factor: 2.497

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.